AlzChem Group AG (ALZCF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AlzChem Group AG

    PNK: ALZCF · Real-Time Price · USD
    101.30
    0.00 (0.00%)
    At close: Apr 30, 2025, 1:48 PM

    AlzChem Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 139.04M 128.94M 136.19M 150.06M 263.62M 120.82M 126.6M 150.43M 133.2M 139.19M 140.44M 129.4M 111.05M 95.92M 111M 104.32M
    Cost of Revenue
    		 43.58M 44.86M 202.33M 59.76M 190.11M 48.4M 52.33M 75.24M 63.28M 77.27M 57.6M 59.39M 40.62M 35.8M 37.38M 38.37M
    Gross Profit
    		 95.46M 84.08M -66.14M 90.31M 73.51M 72.43M 74.27M 75.19M 69.92M 61.93M 82.83M 70M 70.43M 60.12M 73.62M 65.95M
    Operating Income
    		 20.7M 18.48M 47.09M 18.38M 28.93M 13.62M 11.64M 12.65M 33.34M 5.82M 13.9M 11.95M 5.64M 7.77M 13.34M 11.46M
    Interest Income
    		 744K 450K 687K 292K 227K 661K 106K 49K 1.65M 2.47M 2.39M 1.18M 3K 139K 244K 513K
    Pretax Income
    		 20.85M 17.39M 19.89M 17.21M 27.44M 12.04M 9.98M 10.77M 9.14M 7.54M 13.26M 11.34M 5.21M 7.34M 12.92M 11.04M
    Net Income
    		 15.12M 12.38M 14.38M 12.19M 19.76M 8.61M 7.2M 7.67M 6.83M 5.93M 9.59M 7.7M 5.84M 4.69M 9.17M 7.89M
    Selling & General & Admin
    		 n/a n/a 8.78M 40.59M 32.22M 34.68M 7.71M 36.09M 30.17M 31.32M 12.82M 34.35M 27.78M 30.88M 7.11M 33.22M
    Research & Development
    		 n/a n/a n/a n/a 4.54M n/a 3.32M n/a 10.79M n/a n/a n/a 9.69M n/a n/a n/a
    Other Expenses
    		 74.76M 84.08M 63.27M n/a -7.83M n/a -6.07M n/a -5.27M n/a -4.27M n/a -4.24M n/a -4.19M n/a
    Operating Expenses
    		 74.76M 84.08M 47.83M 71.93M 44.58M 59.47M 62.09M 62.59M 67.45M 56.1M 72.91M 59.24M 64.56M 52.48M 59.95M 55M
    Interest Expense
    		 1.47M 1.54M 1.37M 1.45M 2.47M 1.59M 1.66M 1.88M 1.03M 753K 643K 603K n/a 431K 414K 425K
    Selling & Marketing Expenses
    		 n/a n/a 4.8M n/a n/a n/a 4.89M n/a n/a n/a 6.8M n/a n/a n/a 4.42M n/a
    Cost & Expenses
    		 118.34M 128.94M 136.19M 131.69M 234.69M 107.86M 114.42M 137.83M 130.73M 133.37M 130.51M 118.63M 105.19M 88.29M 97.33M 93.37M
    Income Tax Expense
    		 5.68M 4.97M 5.46M 4.98M 7.6M 3.38M 2.74M 3.06M 2.27M 1.56M 3.63M 3.6M -679K 2.61M 3.71M 3.11M
    Shares Outstanding (Basic)
    		 10.18M 10.18M 10.18M 10.18M 10.14M 10.13M 10.16M 10.15M 10.14M 10.06M 10.14M 10.14M 10.14M 10.2M 10.15M 10.17M
    Shares Outstanding (Diluted)
    		 10.18M 10.18M 10.18M 10.18M 10.14M 10.13M 10.16M 10.15M 10.14M 10.06M 10.14M 10.14M 10.14M 10.2M 10.15M 10.17M
    EPS (Basic)
    		 1.49 1.22 1.41 1.20 1.95 0.85 1.46 0.76 1.26 0.59 0.95 0.76 0.58 0.46 0.90 0.78
    EPS (Diluted)
    		 1.49 1.22 1.41 1.20 1.95 0.85 1.46 0.76 1.26 0.59 0.95 0.76 0.58 0.46 0.90 0.78
    EBITDA
    		 29.25M 25.33M 25.95M 25.2M 24.61M 19.53M 17.7M 18.97M 16.79M 12.15M 20.2M 16.56M 12.24M 13.84M 19.76M 15.96M
    EBIT
    		 22.32M 18.93M 21.25M 18.67M 17.94M 13.62M 11.64M 12.65M 10.18M 8.29M 13.9M 11.95M 5.64M 7.77M 13.34M 11.46M
    Depreciation & Amortization
    		 6.93M 6.4M 6.45M 6.54M 13.24M 6.57M 12.65M 6.32M 12.94M 6.32M 12.6M 6.3M 12.8M 6.21M 11.67M 5.77M

    Add to Watchlist